SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-027570
Filing Date
2022-10-04
Accepted
2022-10-04 16:50:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 33682
2 ex99-1.htm EX-99.1 13914
3 ex99-1_001.jpg GRAPHIC 10880
  Complete submission text file 0001493152-22-027570.txt   63966
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40023 | Film No.: 221292550
SIC: 2834 Pharmaceutical Preparations